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High concentrations of cholecystokinin (CCK)-and bombesin-like activities have been found in the hypothalamus (Innis et al., 1979 ; Brown et al., 1978) . Gibbs et al. (1977) found that CCK and bombesin have some common biological actions. In fact, intraventricular administrations of both peptides decreased the appetite (Gibbs et al.; Morley, 1980) and produced a hypothermia (CCK : Katsuura et al., personal communication ; bombesin : Brown et al., 1977) These peptides stimulate exocrine pancreatic secretions and produce contractions of the gall bladder (Williams, 1981) . In addition, bombesin is a potent releaser of CCK in dogs (Miyata, 1978 1 mm posterior to the bregma, 1.5 mm lateral to the sagittal suture and 4.0 mm below the surface of the skull. Five to 7 days later, these rats were anesthetized with urethane (150 mg/100 g B.W.) between 10: 00 and 12 : 00 a.m.. CCK octapeptide or bombesin dissolved in physiological saline was injected in a volume of 10 pl into the lateral ventricle. For intravenous administrations, each peptide dissolved in 0.3 ml saline was infused through the heart catheter. FK 33-824, chlorpromazine (CPZ), domperidone or prostaglandin E2 (PGE2) dissolved in 0.3 ml saline was infused through the heart catheter 10 min after the intraventricular injection of CCK or bombesin. Blood (1.0 ml) was withdrawn through the heart catheter before and 10 min, 20 min and 40 min after the injection of CCK and bombesin. An equal volume of saline was injected into the rats after each blood sampling, in order to minimize extracellular volume changes.
The following drugs were used : bombesin (Sigma), CCK octapeptide (Sigma), chlorpromazine (CPZ, Yoshitomi Pham. Co.), Domperidone (Kyowa Hakko Co.), FK 33-824 (D-Ala2-MePhe4, met-(o)enkephalinol : Domme, Sandoz), prostaglandin E2 (PGE2, Ono Pharm. Co.).
Plasma growth hormone (GH) and prolactin (PRL) were determined by double antibody radioimmuno-assay using materials supplied by NIAMDD, NIH. The minimal sensitivities for GH and PRL were 1.5 ng/ml. The intra-and inter-assay coefficients of variation were less than 10%. Statistical analysis of data were performed using Student's t-test. The effects of CCK and bombesin on GH release Concerning the effect of bombesin, Rivier et al. (1978) reported that it increases the GH level in the urethane-anesthetized, estrogen-primed male rat. However, we found that bombesin inhibited the basal GH level, though evaluation of the drop in the basal GH level encounters a problem in urethaneanesthetized rats because of their low basal level (Kato et al., 1973) . reported that in the urethane-anesthetized male rat, bombesin suppresses the PGE2 (iv) or beta-endorphin (ivt)-induced GH release, corresponding to the results of our observations. Concerning the effect of CCK, Vijayan et al. (1979) reported that CCK (ivt) increases the GH release in conscious rat. It has not been reported, however, that CCK has an inhibitory action on GH release. The cause of these discrepancies cannot be explained, though they may be partly due to different experimental conditions.
Neither CCK nor bombesin is reported to inhibit the GH secretions in in vitro experiments (Westendorf and Schoubrunn, 1982 : Malarkey et al., 1981) . In this study the inhibitory effects of the two peptides on the GH release were more potent when administered intraventricularly than intravenously. These results suggest central sites of actions of these peptides. Abe et al. (1981a) reported that bombesin appears to stimulate the secretion of somatostatin from the hypothalamus into hypophysial portal blood, thereby inhibiting GH release from the anterior pituitary in Fig. 3 factor (GRF), without changing the somatostatin level in hypophysial portal blood (Abe et al., 1981b) . CPZ increases the GH release in urethane-anesthetized rat by antidopaminergic rather antinoradrenergic action (Weiner and Ganog, 1981) . As domperidone, which does not cross the blood brain barrier, did not increase the plasma GH, the CPZ-induced GH release is thought to be due to central antidopaminergic action, though it cannot be decided whether dopamine stimulates a GRF release or/and inhibits a somatostatin release in anesthetized rat. On the other hand, PGE2 is thought to act directly on the pituitary in the rat (Lee, 1981) . Therefore, these findings suggested that CCK and bombesin may increase somatostatin from the hypothalamus, thus suppressing the Gil release induced by GRF or PGE2 on a pituitary level.
The effects of CCK and bombesin on PRL release Neither CCK nor bombesin is reported to release the PRL in in vitro experiments (Westendorf and Schoubrunn, 1982: Malarkey et al., 1981) . In this study, the in- 
